Canine Flu H3N2
The first fully licensed vaccine for dogs and cats to protect against canine influenza H3N2 infections.
PROVIDING PROTECTION AGAINST H3N2
Nobivac® Canine Flu H3N2 (Inactived virus).
- Reduced the incidence and severity of coughing1
- Decreased the overall clinical signs of disease, including ocular and nasal discharge, coughing, sneezing, depression, and dyspnea1
- Demonstrated protection against the formation and severity of lung lesions1
- Contains inactivated virus; adjuvanted to enhance immune response
- For Cats:
- Induces high antibody response to vaccination
- Protected against pneumonia
- Significantly reduced lung consolidation compared to control cats
Indications:
This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older or healthy cats 10 weeks of age or older against canine influenza virus.
CANINE INFLUENZA VACCINE H3N2 IS A SAFE CHOICE FOR DOGS AND CATS
- Well tolerated on subcutaneous administration
- Proven safe across a multitude of breeds and ages
ADMINISTRATION AND DOSAGE
- 1 mL subcutaneous injection
- Booster two to four weeks later
- Annual revaccination with one dose is recommended
- Available in a 25 x 1 mL dose presentation
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
Nobivac® Social Media Kits
Digital Assets
Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.
AAHA Canine Vaccination Guidelines
In-depth information about canine vaccinations and veterinary best practices.
Addressing CIV in Your Clinic
eBook
Tips and guidelines for your clinic to prevent and manage canine influenza.
No items to show.
Loading…
References:
1. Data on file, Merck Animal Health.
